BIOLOGICAL SIGNIFICANCE AND THERAPEUTIC POTENTIAL OF PROSTACYCLIN

被引：42

作者：

MONCADA, S

VANE, JR

机构：

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1980年 / 23卷 / 06期

关键词：

D O I：

10.1021/jm00180a001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：591 / 593

页数：3

共 24 条

[1]

BUNTING S, 1979, PROSTACYCLIN, P361

[2]

COPPE D, 1979, PROSTACYCLIN, P371

[3] RECIRCULATION OF PROSTACYCLIN (PGI2) IN DOG [J].

DUSTING, GJ ;

MONCADA, S ;

VANE, JR .

BRITISH JOURNAL OF PHARMACOLOGY, 1978, 64 (02) :315-320

[4]

GLAVIND J, 1952, ACTA PATHOL MIC SC, V30, P1

[5] MODULATION OF HUMAN PLATELET ADENYLATE-CYCLASE BY PROSTACYCLIN (PGX) [J].

GORMAN, RR ;

BUNTING, S ;

MILLER, OV .

PROSTAGLANDINS, 1977, 13 (03) :377-388

[6] GENERATION OF PROSTACYCLIN BY LUNGS INVIVO AND ITS RELEASE INTO ARTERIAL CIRCULATION [J].

GRYGLEWSKI, RJ ;

KORBUT, R ;

OCETKIEWICZ, A .

NATURE, 1978, 273 (5665) :765-767

[7] ARTERIAL-WALLS ARE PROTECTED AGAINST DEPOSITION OF PLATELET THROMBI BY A SUBSTANCE (PROSTAGLANDIN-X) WHICH THEY MAKE FROM PROSTAGLANDIN ENDOPEROXIDES [J].

GRYGLEWSKI, RJ ;

BUNTING, S ;

MONCADA, S ;

FLOWER, RJ ;

VANE, JR .

PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (05) :685-713

[8] THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].

HAMBERG, M ;

SVENSSON, J ;

SAMUELSSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998

[9]

HENSBY CN, 1979, LANCET, V2, P1162

[10] CHEMICAL-STRUCTURE OF PROSTAGLANDIN-X (PROSTACYCLIN) [J].

JOHNSON, RA ;

MORTON, DR ;

KINNER, JH ;

GORMAN, RR ;

MCGUIRE, JC ;

SUN, FF ;

WHITTAKER, N ;

BUNTING, S ;

SALMON, J ;

MONCADA, S ;

VANE, JR .

PROSTAGLANDINS, 1976, 12 (06) :915-928

← 1 2 3 →